Thoratec Corp. of Pleasanton warned consumers late Tuesday that four patients, including two who improperly used the company's popular heart pump device, had died. The users had experienced problems ...
HeartMate III is a next-generation continuous flow left ventricular assist device (:LVAD) based on fully magnetically levitated technology. This technology helps in reducing adverse event rates ...
With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST.
In March Abbott Laboratories (NYSE:ABT) pulled the control unit for its HeartMate II pump off the US market. The FDA has now designated the recall class I – the most serious type – making public the ...
ST. PAUL, Minn.-- (BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the company has received an Innovation Award for its HeartMate 3 ™ Left ...
November 17, 2009 (Orlando, Florida) — Advanced heart-failure transplant-ineligible patients with Thoratec's HeartMate II continuous-flow left-ventricular assist device (LVAD) have better-than-even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results